A Member of the University of Maryland Medical System   |   In Partnership with the University of Maryland School of Medicine

Share

Email PageEmail Print PagePrint

Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

Progressive supranuclear palsy - All Information

Alternative Names

Dementia-nuchal dystonia; Richardson-Steele-Olszewski syndrome; Palsy - progressive supranuclear

Definition of Progressive supranuclear palsy:

Progressive supranuclear palsy is a movement disorder that occurs from damage to certain nerve cells in the brain.

Causes, incidence, and risk factors:

Progressive supranuclear palsy is a condition that causes symptoms similar to those of Parkinson's disease.

It involves damage to many cells of the brain. Many areas are affected, including the part of the brainstem where cells that control eye movement are located. Also affected is an area of the brain that controls steadiness when you walk. The frontal lobes of the brain are also affected, leading to personality changes.

The cause of the damage to the brain cells is unknown. The disease gets worse over time.

People with this condition have deposits in brain tissues that look like those found in patients with Alzheimer's disease. There is a loss of tissue in most areas of the brain and in some parts of the spinal cord.

The disorder is most often seen in people over 60 years old, and is somewhat more common in men.

Symptoms:

  • Changes in expressions of the face
  • Deeply lined face
  • Difficulty moving the eyes or lack of control over the eyes
  • Different size pupils
  • Difficulty swallowing
  • General slowness of movement (bradykinesia)
  • Jaw or face jerks or spasms
  • Loss of coordination, unsteady gait (walking pattern)
  • Mild-to-moderate dementia
    • Difficulty using knowledge
    • Forgetfulness
    • Indifference (apathy)
    • Slowed thought processes
  • Personality changes
  • Repeated falls
  • Slow or stiff movements
  • Speech difficulties
    • Low voice volume
    • Poor ability to speak clearly (enunciate)
    • Slow speech
  • Stiffness and rigid movement in the neck, middle of the body, arms, legs
  • Tremor
  • Vision difficulty -- unable to look up or down without bending the neck

Signs and tests:

An exam of the nervous system (neurological examination) may show:

  • Dementia that is getting worse
  • Limited eye movements, especially up and down movements
  • Normal vision, hearing, sensation, and voluntary control of movement
  • Stiff and uncoordinated movements like those of Parkinson's disease

The health care provider may do tests to rule out other diseases. Magnetic resonance imaging (MRI) might show shrinking of the brainstem.

Treatment:

The goal of treatment is to control symptoms. There is no known cure for progressive supranuclear palsy.

Levodopa or other drugs, such as benztropine or trihexyphenidyl, which block the action of a nervous system chemical called acetylcholine (anticholinergic medications) may temporarily reduce some symptoms, such as rigid limbs or slow movements. However, these medications are usually not as effective as they are for Parkinson's disease.

Many people with this condition will need around-the-clock care and monitoring as they lose brain functions.

Expectations (prognosis):

Treatment sometimes can reduce symptoms temporarily, but the condition will get worse. Brain function will decline over time. Death commonly occurs in 5 to 7 years.

Complications:

  • Blood clot in veins (deep vein thrombosis) due to limited mobility
  • Lack of control over gaze
  • Loss of brain functions over time
  • Pneumonia due to difficulty swallowing
  • Poor nutrition (malnutrition)
  • Side effects from medications

Calling your health care provider:

Call your health care provider if you often fall, and if you have a stiff neck/body and vision problems.

Also, call if a loved one has been diagnosed with progressive supranuclear palsy and the condition has declined so much that you can no longer care for the person at home.

  • Reviewed last on: 5/5/2010
  • David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

References

Goetz CG. Textbook of Clinical Neurology. 3rd ed. Philadelphia, Pa: Saunders; 2007.

Lang A. Parkinsonism. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier;2007:chap 433.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com
 
Adam QualityA.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com
Connect with UMMC
Facebook Twitter YouTube Blog iPhone

Please rate the quality of this article.

Do you find this article to be helpful / informative?
              
Poor                                       Excellent

Do you have any brief comments on this page: (up to 255 characters)

© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885